The possible hypertensive effect of oral contraceptives is a controver
sial issue. We studied 371 women, admitted to the family planning prog
ram of a state funded outpatient clinic, that were followed during 12
months. These women were divided in four groups: Group 1 was constitut
ed by 98 women that used intrauterine devices. Group 2 by 98 women tak
ing 30 mu g of estrogen and 300 mu g of progestogen. Group 3 by 83 wom
en taking 35 mu g of estrogen and 500 mu g of progestogen and Group 4
by 92 puerperal women taking 30 mu g of levonorgestrel, that after six
months started to use an intrauterine device (n = 35) or the contrace
ptives of group 2 (n = 38) or group 3 (n = 19). Age, initial blood pre
ssure and weight were similar in the four groups. There was no signifi
cant change in blood pressure after 6 or 12 months of follow up in any
group. It is concluded that contraceptives containing estrogen concen
trations up to 35 mu g and progestogen concentrations between 300 and
500 mu g do not induced changes in blood pressure.